|
SG10202003901UA
(en)
|
2005-12-13 |
2020-05-28 |
Incyte Holdings Corp |
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
|
|
KR20150036210A
(ko)
|
2007-06-13 |
2015-04-07 |
인사이트 코포레이션 |
야누스 키나제 억제제（Ｒ）―３―（４―（７Ｈ―피롤로［２，３－ｄ］피리미딘―4―일）―1Ｈ―피라졸―1―일）―３―사이클로펜틸프로판니트릴의 염
|
|
EP2348860B1
(en)
|
2008-10-31 |
2015-05-27 |
Genentech, Inc. |
Pyrazolopyrimidine jak inhibitor compounds and methods
|
|
SI2432472T1
(sl)
|
2009-05-22 |
2019-11-29 |
Incyte Holdings Corp |
3-(4-(7H-pirolo(2,3-d)pirimidin-4-il)-1H-pirazol-1-il)oktan- ali heptan-nitril kot inhibitorji JAK
|
|
KR101763656B1
(ko)
|
2009-06-29 |
2017-08-01 |
인사이트 홀딩스 코포레이션 |
Ｐｉ3ｋ 저해물질로서의 피리미디논
|
|
UA110324C2
(en)
|
2009-07-02 |
2015-12-25 |
Genentech Inc |
Jak inhibitory compounds based on pyrazolo pyrimidine
|
|
US8759359B2
(en)
|
2009-12-18 |
2014-06-24 |
Incyte Corporation |
Substituted heteroaryl fused derivatives as PI3K inhibitors
|
|
EP3354652B1
(en)
|
2010-03-10 |
2020-05-06 |
Incyte Holdings Corporation |
Piperidin-4-yl azetidine derivatives as jak1 inhibitors
|
|
EP2558463A1
(en)
|
2010-04-14 |
2013-02-20 |
Incyte Corporation |
Fused derivatives as i3 inhibitors
|
|
PE20130216A1
(es)
|
2010-05-21 |
2013-02-27 |
Incyte Corp |
Formulacion topica para un inhibidor de jak
|
|
WO2011163195A1
(en)
|
2010-06-21 |
2011-12-29 |
Incyte Corporation |
Fused pyrrole derivatives as pi3k inhibitors
|
|
US9040545B2
(en)
|
2010-08-20 |
2015-05-26 |
Cellzome Limited |
Heterocyclyl pyrazolopyrimidine analogues as selective JAK inhibitors
|
|
TW201217387A
(en)
|
2010-09-15 |
2012-05-01 |
Hoffmann La Roche |
Azabenzothiazole compounds, compositions and methods of use
|
|
PE20140146A1
(es)
|
2010-11-19 |
2014-02-06 |
Incyte Corp |
Derivados de pirrolopiridina y pirrolopirimidina sustituidos con ciclobutilo como inhibidores de jak
|
|
BR112013011520A2
(pt)
*
|
2010-11-19 |
2019-09-24 |
Hoffmann La Roche |
pirazolo piridinas e pirazolo piridinas e seu uso como inibidores de tyk2
|
|
EP3660016A1
(en)
|
2010-12-20 |
2020-06-03 |
Incyte Holdings Corporation |
N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors
|
|
US9108984B2
(en)
|
2011-03-14 |
2015-08-18 |
Incyte Corporation |
Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors
|
|
WO2012135009A1
(en)
|
2011-03-25 |
2012-10-04 |
Incyte Corporation |
Pyrimidine-4,6-diamine derivatives as pi3k inhibitors
|
|
WO2012143320A1
(en)
|
2011-04-18 |
2012-10-26 |
Cellzome Limited |
(7h-pyrrolo[2,3-d]pyrimidin-2-yl)amine compounds as jak3 inhibitors
|
|
CN103797010B
(zh)
|
2011-06-20 |
2016-02-24 |
因塞特控股公司 |
作为jak抑制剂的氮杂环丁烷基苯基、吡啶基或吡嗪基甲酰胺衍生物
|
|
EP2736901A1
(en)
|
2011-07-28 |
2014-06-04 |
Cellzome Limited |
Heterocyclyl pyrimidine analogues as jak inhibitors
|
|
WO2013017480A1
(en)
|
2011-07-29 |
2013-02-07 |
Cellzome Limited |
Pyrazolo[4,3-c]pyridine derivatives as jak inhibitors
|
|
WO2013017479A1
(en)
|
2011-07-29 |
2013-02-07 |
Cellzome Limited |
Pyrazolo[4,3-c]pyridine derivatives as jak inhibitors
|
|
PT3513793T
(pt)
|
2011-09-02 |
2021-05-10 |
Incyte Holdings Corp |
Heterociclilaminas como inibidores de pi3k
|
|
UA111854C2
(uk)
|
2011-09-07 |
2016-06-24 |
Інсайт Холдінгс Корпорейшн |
Способи і проміжні сполуки для отримання інгібіторів jak
|
|
CN103874699A
(zh)
*
|
2011-09-20 |
2014-06-18 |
赛尔佐姆有限公司 |
吡唑并[4,3-c]吡啶衍生物作为激酶抑制剂
|
|
CN104169272A
(zh)
|
2011-12-23 |
2014-11-26 |
赛尔佐姆有限公司 |
作为激酶抑制剂的嘧啶-2,4-二胺衍生物
|
|
CN103193600B
(zh)
*
|
2012-01-07 |
2016-04-06 |
浙江九洲药物科技有限公司 |
卡巴拉汀中间体的制备方法
|
|
ES2655264T3
(es)
*
|
2012-01-28 |
2018-02-19 |
Merck Patent Gmbh |
Derivados de triazolo[4,5-d]pirimidina
|
|
AR090548A1
(es)
|
2012-04-02 |
2014-11-19 |
Incyte Corp |
Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
|
|
BR112014029310A2
(pt)
|
2012-05-24 |
2018-06-26 |
Cellzome Ltd |
análogos da pirimidina heterocíclica como inibidores da tyk2
|
|
PH12020551186B1
(en)
|
2012-11-15 |
2024-03-20 |
Incyte Holdings Corp |
Sustained-release dosage forms of ruxolitinib
|
|
CA2897279C
(en)
|
2013-01-23 |
2020-12-29 |
Astrazeneca Ab |
Aminopyrazine derivatives and pharmaceutical compositions thereof for use in the treatment of cancer
|
|
RS62867B1
(sr)
|
2013-03-06 |
2022-02-28 |
Incyte Holdings Corp |
Postupci i intermedijeri za dobijanje inhibitora jak
|
|
SMT202000315T1
(it)
|
2013-08-07 |
2020-07-08 |
Incyte Corp |
Forme di dosaggio a rilascio prolungato per un inibitore di jak1
|
|
WO2015038417A1
(en)
*
|
2013-09-10 |
2015-03-19 |
Asana Biosciences, Llc |
Compounds for regulating fak and/or src pathways
|
|
WO2015058024A1
(en)
|
2013-10-17 |
2015-04-23 |
Dow Agrosciences Llc |
Processes for the preparation of pesticidal compounds
|
|
JP2017516850A
(ja)
|
2014-05-23 |
2017-06-22 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
Ｊａｋ阻害剤である５−クロロ−２−ジフルオロメトキシフェニルピラゾロピリミジン化合物
|
|
US9498467B2
(en)
|
2014-05-30 |
2016-11-22 |
Incyte Corporation |
Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1
|
|
TW201613916A
(en)
|
2014-06-03 |
2016-04-16 |
Gilead Sciences Inc |
TANK-binding kinase inhibitor compounds
|
|
WO2015191677A1
(en)
|
2014-06-11 |
2015-12-17 |
Incyte Corporation |
Bicyclic heteroarylaminoalkyl phenyl derivatives as pi3k inhibitors
|
|
NZ729618A
(en)
|
2014-09-26 |
2018-07-27 |
Gilead Sciences Inc |
Aminotriazine derivatives useful as tank-binding kinase inhibitor compounds
|
|
SG10201907576SA
(en)
|
2015-02-27 |
2019-09-27 |
Incyte Corp |
Salts of pi3k inhibitor and processes for their preparation
|
|
US10259816B2
(en)
*
|
2015-04-24 |
2019-04-16 |
Guangzhou Maxinovel Pharmaceuticals Co., Ltd. |
Condensed-ring pyrimidylamino derivative, preparation method therefor, and intermediate, pharmaceutical composition and applications thereof
|
|
US9732097B2
(en)
|
2015-05-11 |
2017-08-15 |
Incyte Corporation |
Process for the synthesis of a phosphoinositide 3-kinase inhibitor
|
|
US9988401B2
(en)
|
2015-05-11 |
2018-06-05 |
Incyte Corporation |
Crystalline forms of a PI3K inhibitor
|
|
CU20180059A7
(es)
|
2015-12-17 |
2018-10-04 |
Gilead Sciences Inc |
Compuestos inhibidores de la quinasa de unión a tank
|
|
AU2017302635B2
(en)
*
|
2016-07-29 |
2021-09-16 |
Rapt Therapeutics, Inc. |
Chemokine receptor modulators and uses thereof
|
|
CN110325036B
(zh)
*
|
2016-12-29 |
2021-10-26 |
美国陶氏益农公司 |
用于制备杀虫化合物的方法
|
|
WO2018125815A1
(en)
|
2016-12-29 |
2018-07-05 |
Dow Agrosciences Llc |
Processes for the preparation of pesticidal compounds
|
|
PL233595B1
(pl)
*
|
2017-05-12 |
2019-11-29 |
Celon Pharma Spolka Akcyjna |
Pochodne pirazolo[1,5-a]pirymidyny jako inhibitory kinazy JAK
|
|
MX387969B
(es)
|
2017-05-22 |
2025-03-19 |
Hoffmann La Roche |
Composiciones y compuestos terapéuticos, y métodos para su uso.
|
|
AU2018381574B2
(en)
*
|
2017-12-05 |
2022-09-15 |
Oscotec Inc. |
Pyrrolo(pyrazolo)pyrimidine derivative as LRRK2 inhibitor
|
|
WO2019113487A1
(en)
|
2017-12-08 |
2019-06-13 |
Incyte Corporation |
Low dose combination therapy for treatment of myeloproliferative neoplasms
|
|
SG11202007164UA
(en)
|
2018-01-30 |
2020-08-28 |
Incyte Corp |
Processes for preparing (1 -(3-fluoro-2-(trifluoromethyl)isonicotinyl)piperidine-4-one)
|
|
IL276745B2
(en)
|
2018-02-28 |
2023-10-01 |
Basf Se |
Use of N-functional alkoxy pyrazole compounds as nitrification inhibitors
|
|
EP3758491A1
(en)
|
2018-02-28 |
2021-01-06 |
Basf Se |
Use of pyrazole propargyl ethers as nitrification inhibitors
|
|
SMT202400306T1
(it)
|
2018-03-30 |
2024-09-16 |
Incyte Corp |
Trattamento dell'idrosadenite suppurativa utilizzando inibitori di jak.
|
|
SG11202011680YA
(en)
|
2018-06-01 |
2020-12-30 |
Incyte Corp |
Dosing regimen for the treatment of pi3k related disorders
|
|
CN110885331B
(zh)
*
|
2018-09-11 |
2021-07-09 |
中国药科大学 |
一种6-氨基-1H-吡唑并[3，4-d]嘧啶类JAK激酶抑制剂的制备与应用
|
|
SG11202103011YA
(en)
*
|
2018-10-11 |
2021-04-29 |
Basf As |
Aromatic compounds and pharmaceutical uses thereof
|
|
WO2020092015A1
(en)
|
2018-11-02 |
2020-05-07 |
University Of Rochester |
Therapeutic mitigation of epithelial infection
|
|
CA3139277A1
(en)
|
2019-05-08 |
2020-11-12 |
Vimalan Biosciences, Inc. |
Jak inhibitors
|
|
TWI899080B
(zh)
*
|
2019-05-27 |
2025-10-01 |
大陸商迪哲（江蘇）醫藥股份有限公司 |
Ｄｎａ依賴性蛋白激酶抑制劑
|
|
MX2022001702A
(es)
*
|
2019-08-08 |
2022-04-20 |
Vimalan Biosciences Inc |
Inhibidores de jak.
|
|
US20230065636A1
(en)
*
|
2020-01-15 |
2023-03-02 |
KSQ Therapeutics, Inc. |
Compositions of substituted pyrazolopyrimidines and uses thereof
|
|
US11833155B2
(en)
|
2020-06-03 |
2023-12-05 |
Incyte Corporation |
Combination therapy for treatment of myeloproliferative neoplasms
|
|
KR20230098186A
(ko)
|
2020-10-30 |
2023-07-03 |
케이에스큐 세러퓨틱스 인코포레이티드 |
치환된 피라졸로피리미딘의 고체 상태 형태 및 이의 용도
|
|
EP4341248A1
(en)
|
2021-05-21 |
2024-03-27 |
Basf Se |
Use of an n-functionalized alkoxy pyrazole compound as nitrification inhibitor
|
|
WO2024238570A1
(en)
*
|
2023-05-15 |
2024-11-21 |
Aleksia Therapeutics, Inc. |
Cdk2 inhibitor pyrazolopyrimidine compounds
|